| Excerpt | Relevance | Reference |
|---|
| "Pyridoxamine (PM) is a structural analog of vitamin B6 that interferes with oxidative macromolecular damage via a number of different mechanisms and is in a phase 3 clinical efficacy trial to delay CKD progression in patients with diabetic kidney disease." | 5.43 | Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury. ( de Caestecker, CR; de Caestecker, MP; Drouin, M; Harris, RC; Hudson, B; Skrypnyk, NI; Theberge, MC; Voziyan, P; Yang, H, 2016) |
| "Pyridoxamine (PM) is a structural analog of vitamin B6 that interferes with oxidative macromolecular damage via a number of different mechanisms and is in a phase 3 clinical efficacy trial to delay CKD progression in patients with diabetic kidney disease." | 1.43 | Pyridoxamine reduces postinjury fibrosis and improves functional recovery after acute kidney injury. ( de Caestecker, CR; de Caestecker, MP; Drouin, M; Harris, RC; Hudson, B; Skrypnyk, NI; Theberge, MC; Voziyan, P; Yang, H, 2016) |